Immunic Names New CEO
Immunic appoints Erik Lundgren as CEO as it advances Phase 3 multiple sclerosis trials. This move may impact the company's strategic direction.
Site Search
Search market news
Find public news by keyword, exact ticker, category and date.
Matching instruments
Open a ticker page for its news coverage. The news search below stays a text search.
News Feed
3 results loaded, newest first. End of these results. The latest changes are still being indexed. Try again shortly for updated results.
Immunic names Lundgren CEO
Immunic appoints new chief executive officer Erik Lundgren
Immunic Names Lundgren CEO
Immunic appoints former Genentech executive Erik Lundgren as CEO, potentially impacting the company's strategy and direction. This move may have implications for the biotech industry.